Back to Oxyuranus
pageAlvarez, J. and S.-J. Garc'ia (1989). "Inhibition of red cell Ca2+-dependent K+ channels by snake venoms." Biochim-Biophys-Acta 980(2): 134-8.
Aronson, D. L., B. R. Franza, et al. (1984). "The use of prothrombin activating snake venoms to measure human prethrombin 2: absence of prethrombin 2 in serum." Thromb. Res. 34(5): 419-29.
Arthur, C. K., D. McCallum, et al. (1991). "Effects of taipan (Oxyuranus scutellatus) venom on erythrocyte morphology and blood viscosity in a human victim in vivo and in vitro." Trans-R-Soc-Trop-Med-Hyg 85(3): 401-3.
Azhar, A., F. S. Ausat, et al. (1996). "Snake venoms as probes to study the kinetics of formation and architecture of fibrin network structure." Adv. Exp. Med. Biol. 391(Natural Toxins 2): 417-425.
Barnett, D. and M. E. H. Howden (1983). "A novel method for selective isolation of lethal glycoprotein toxins from snake venoms." Toxicon 3: 33-6.
Bennett, E. A. (1992). Taipan venom procoagulant and protein-protein interactions. Recent Adv. Toxinol. Res., [World Conf. Anim., Plant Microb. Toxin], 10th, Natl. Univ. Singapore, Venom Toxin Res. Group, Singapore, Singapore.
Broad, A. J., S. K. Sutherland, et al. (1979). "Electrophoretic, enzyme, and preliminary toxicity studies of the venom of the small-scaled snake, Parademansia microlepidota (serpentes: Elapidae), with additional data on its distribution." Mem. Queensl. Mus. 19(3): 319-29.
Brown, A. M., A. Yatani, et al. (1987). "Neurotoxins that act selectively on voltage-dependent cardiac calcium channels." Circ-Res 61(4 Pt 2): I6-9.
Chester, A. and G. P. M. Crawford (1982). "In vitro coagulant properties of venoms from Australian snakes." Toxicon 20(2): 501-4.
Connolly, S., A. J. Trevett, et al. (1995). "Neuromuscular effects of Papuan taipan snake venom." Ann. Neurol. Volume Date 1995, 38(6): 916-20.
Crosland, R. D. (1989). "Effect of chlorpromazine and quinacrine on the lethality in mice of the venoms and neurotoxins from several snakes." Toxicon 27(6): 655-63.
Crosland, R. D. (1990). "Effect of drugs on the lethality in mice of the venoms and neurotoxins from sundry snakes." Report(AD): 968.
Crosland, R. D. (1991). "Effect of drugs on the lethality in mice of the venoms and neurotoxins from sundry snakes." Toxicon 29(6): 613-31.
Currie, B. J., S. K. Sutherland, et al. (1991). "An epidemiological study of snake bite envenomation in Papua New Guinea [see comments]." Med-J-Aust 154(4): 266-8.
Denson, K. W. E. (1976). "The clotting of a snake (Crotalus viridis helleri) plasma and its interaction with various snake venoms." Thromb. Haemostasis 35(2): 314-23.
Denson, K. W. E., R. Borrett, et al. (1971). "Specific assay of prothrombin using the Taipan snake venom." Brit. J. Haematol. 21(2): 219-26.
Fischer, B. E., U. Schlokat, et al. (1996). "Differentiation between proteolytic activation and autocatalytic conversion of human prothrombin. Activation of recombinant human prothrombin and recombinant D419N-prothrombin by snake venoms from Echis carinatus and Oxyuranus scutellatus." Protein Eng. 9(10): 921-926.
Fischer, B. E., U. Schlokat, et al. (1996). "Rational design, recombinant preparation, and in vitro and in vivo characterization of human prothrombin-derived hirudin antagonists." J. Biol. Chem. 271(39): 23737-23742.
Fohlman, J. (1979). "Comparison of two highly toxic Australian snake venoms: the Taipan ( Oxyuranus s. scutellatus) and the fierce snake (Parademansia microlepidotus)." Toxicon 17(2): 170-2.
Fohlman, J., D. Eaker, et al. (1976). "Taipoxin, an extremely potent presynaptic neurotoxin from the venom of the Australian snake taipan ( Oxyuranus s. scutellatus). Isolation, characterization, quaternary structure and pharmacological properties." Eur. J. Biochem. 68(2): 457-69.
Fohlman, J., P. Lind, et al. (1977). "Taipoxin, an extremely potent presynaptic snake venom neurotoxin. Elucidation of the primary structure of the acidic carbohydrate-containing taipoxin-subunit, a prophospholipase homolog." FEBS Lett. 84(2): 367-71.
Fossier, P., G. Lambeau, et al. (1995). "Inhibition of ACh release at an Aplysia synapse by neurotoxic phospholipases A2: specific receptors and mechanisms of action." J. Physiol. 489(1): 29-40.
Gandolfo, G., G. Lambeau, et al. (1996). "Effects on behavior and EEG of single chain phospholipases A2 from snake and bee venoms injected into rat brain: search for a functional antagonism." Pharmacol. Toxicol. 78(5): 341-347.
Girolami, A., G. Patrassi, et al. (1976). "Viper venoms and coumarin-induced prothrombin. A comparison of several one-stage methods employing three different venoms as thromboplastins." Ric. Clin. Lab. 6(1): 55-68.
Girolami, A., G. Petrassi, et al. (1981). "Taipan viper venom and chromogenic substrate (chromozym Th). Prothrombin assay. No sensitivity to coumarin-induced prothrombin." Folia-Haematol-Int-Mag-Klin-Morphol-Blutforsch 108(6): 822-30.
Gorman, J. J. and P. A. Castaldi (1974). "Isolation and characterization of multiple forms of human thrombin." Thromb. Res. 4(5): 653-73.
Guillin, M. C. and A. Bezeaud (1981). "Characterization of a variant of human prothrombin: prothrombin Madrid." Ann. N. Y. Acad. Sci. 370(Contrib. Hemostasis): 414-25.
Hagglund, U. and M. Blomback (1986). "Amidolytic assay of factor V in human plasma." Thromb-Res 41(1): 79-88.
Hamilton, R. C., A. J. Broad, et al. (1980). "Ultrastructural effects of the venom of the small-scaled snake (Parademansia microlepidotus) on the nerve terminals of the rat diaphragm." Aust-J-Exp-Biol-Med-Sci 58(4): 377-80.
Harris, J. B. and C. A. Maltin (1982). "Myotoxic activity of the crude venom and the principal neurotoxin, taipoxin, of the Australian taipan, Oxyuranus scutellatus." Br-J-Pharmacol 76(1): 61-75.
Kamenskaya, M. A. and S. Thesleff (1974). "Neuromuscular blocking action of an isolated toxin from the elapid ( Oxyuranus scutellactus)." Acta Physiol. Scand. 90(4): 716-24.
Kirchhof, B. R. J., C. Vermeer, et al. (1978). "The determination of prothrombin using synthetic chromogenic substrates; choice of a suitable activator." Thromb. Res. 13(2): 219-32.
Lalloo, D., A. Trevett, et al. (1994). "Neurotoxicity and haemostatic disturbances in patients envenomed by the Papuan black snake (Pseudechis papuanus)." Toxicon 32(8): 927-36.
Lalloo, D. G., A. J. Trevett, et al. (1995). "Snake bites by the Papuan taipan (Oxyuranus scutellatus canni): paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom." Am-J-Trop-Med-Hyg 52(6): 525-31.
Lalloo, D. G., A. J. Trevett, et al. (1995). "Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni)." Blood-Coagul-Fibrinolysis 6(1): 65-72.
Lambeau, G., J. Barhanin, et al. (1991). "Identification of different receptor types for toxic phospholipases A2 in rabbit skeletal muscle." FEBS-Lett 293(1-2): 29-33.
Lambeau, G., J. Barhanin, et al. (1989). "Identification and properties of very high affinity brain membrane-binding sites for a neurotoxic phospholipase from the Taipan venom." J. Biol. Chem. 264(19): 11503-10.
Lambeau, G., M. Lazdunski, et al. (1991). "Properties of receptors for neurotoxic phospholipases A2 in different tissues." Neurochem-Res 16(6): 651-8.
Lambeau, G., A.-A. Schmid, et al. (1990). "Identification and purification of a very high affinity binding protein for toxic phospholipases A2 in skeletal muscle." J-Biol-Chem 265(16): 9526-32.
Lanchantin, G. F., J. A. Friedman, et al. (1973). "Two forms of human thrombin. Isolation and characterization." J. Biol. Chem. 248(17): 5956-66.
Lind, P. (1982). "Amino acid sequence of the .beta.1 isosubunit of taipoxin, an extremely potent presynaptic neurotoxin from the Australian snake taipan ( Oxyuranus s. scutellatus)." Eur. J. Biochem. 128(1): 71-5.
Lind, P. and D. Eaker (1982). "Amino-acid sequence of the alpha-subunit of taipoxin, an extremely potent presynaptic neurotoxin from the Australian snake taipan (Oxyuranus s. scutellatus)." Eur-J-Biochem 124(3): 441-7.
Maltin, C. A., J. B. Harris, et al. (1983). "Regeneration of mammalian skeletal muscle following the injection of the snake-venom toxin, taipoxin." Cell-Tissue-Res 232(3): 565-77.
Maruyama, M., A. S. Kamiguti, et al. (1992). "Prothrombin and factor X activating properties of Bothrops erythromelas venom." Ann-Trop-Med-Parasitol 86(5): 549-56.
Masci, P. P., A. N. Whitaker, et al. (1988). "Purification and characterization of a prothrombin activator from the venom of the Australian brown snake, Pseudonaja textilis textilis." Biochem-Int 17(5): 825-35.
Mebs, D., Y. M. Chen, et al. (1978). "Biochemistry and pharmacology of toxins from Australian snake venoms." Toxicon Volume Date 1976, Suppl. 1(Toxins: Anim., Plant Microb.): 365-73.
Mebs, D. and Y. Samejima (1980). "Purification, from Australian elapid venoms, and properties of phospholipases A which cause myoglobinuria in mice." Toxicon 18(4): 443-54.
Mirtschin, P. J., G. R. Crowe, et al. (1984). "Envenomation by the inland taipan, Oxyuranus microlepidotus." Med-J-Aust 141(12-13): 850-1.
Morrison, J., J. Pearn, et al. (1983). "Studies on the venom of Oxyuranus microlepidotus." J-Toxicol-Clin-Toxicol 21(3): 373-85.
Morrison, J. J., J. H. Pearn, et al. (1982). "The mass of venom injected by two elapidae: the taipan (Oxyuranus scutellatus) and the Australian tiger snake (Notechis scutatus)." Toxicon 20(4): 739-45.
Nakagaki, T., P. Lin, et al. (1992). "Activation of human factor VII by the prothrombin activator from the venom of Oxyuranus scutellatus (Taipan snake)." Thromb-Res 65(1): 105-16.
Owen, W. G. and C. M. Jackson (1973). "Activation of prothrombin with Oxyuranus scutellatus scutellatus (Taipan snake) venom." Thromb. Res. 3(6): 705-14.
Pearn, J. H., J. Covacevich, et al. (1994). "Snakebite in herpetologists." Med-J-Aust 161(11-12): 706-8.
Pirkle, H., M. McIntosh, et al. (1972). "Activation of prothrombin with Taipan snake venom." Thromb. Res. 1(6): 559-68.
Possani, L. D., B. M. Martin, et al. (1992). "Isolation and physiological characterization of taicatoxin, a complex toxin with specific effects on calcium channels." Toxicon 30(11): 1343-64.
Possani, L. D., J. Mochca-Morales, et al. (1992). "Anionic currents of chick sensory neurons are affected by a phospholipase A2 purified from the venom of the taipan snake." Biochim. Biophys. Acta 1134(3): 210-16.
Ramlau, J., E. Bock, et al. (1979). "Production of antivenom against detoxified taipoxin and immunochemical analysis of the .alpha., .beta. and .gamma. subunits." Toxicon 17(1): 43-54.
Rocha, E., J. A. Paramo, et al. (1986). "Prothrombin Segovia: a new congenital abnormality of prothrombin." Scand-J-Haematol 36(5): 444-9.
Speijer, H., R.-J. W. Govers, et al. (1986). "Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake)." J-Biol-Chem 261(28): 13258-67.
Speijer, H., R.-J. W. Govers, et al. (1987). "Platelet procoagulant properties studied with snake venom prothrombin activators." Thromb-Haemost 57(3): 349-55.
Sutherland, S. K. (1992). "Deaths from snake bite in Australia, 1981-1991." Med-J-Aust 157(11-12): 740-6.
Sutherland, S. K., A. J. Broad, et al. (1978). "Australia's potentially most venomous snake: Parademansia microlepidotus." Med-J-Aust 1(5): 288-9.
Tan, N. H., A. Armugam, et al. (1992). "The biological properties of venoms from juvenile and adult taipan (Oxyuranus scutellatus) snakes." Comp-Biochem-Physiol-B 103(3): 585-8.
Trethewie, E. R. and L. Khaled (1972). "Changing antigenic character of venom." T'ai-Wan I Hsueh Hui Tsa Chih 71(6): 431-4.
Trethewie, E. R. and L. Khaled (1973). "Changes in antigenic character of fresh Australian snake venom upon aging." Toxicon 11(1): 55-8.
Trevett, A. J., D. G. Lalloo, et al. (1995). "The efficacy of antivenom in the treatment of bites by the Papuan taipan (Oxyuranus scutellatus canni)." Trans-R-Soc-Trop-Med-Hyg 89(3): 322-5.
Trevett, A. J., D. G. Lalloo, et al. (1995). "Electrophysiological findings in patients envenomed following the bite of a Papuan taipan (Oxyuranus scutellatus canni)." Trans-R-Soc-Trop-Med-Hyg 89(4): 415-7.
Trevett, A. J., D. G. Lalloo, et al. (1995). "Failure of 3,4-diaminopyridine and edrophonium to produce significant clinical benefit in neurotoxicity following the bite of Papuan taipan (Oxyuranus scutellatus canni)." Trans-R-Soc-Trop-Med-Hyg 89(4): 444-6.
Trevett, A. J., D. G. Lalloo, et al. (1995). "Failure of 3,4-diaminopyridine and edrophonium to produce significant clinical benefit in neurotoxicity following the bite of Papuan taipan ( Oxyuranus scutellatus canni)." Trans. R. Soc. Trop. Med. Hyg. 89(4): 444-6.
Tu, A. T. and P. M. Toom (1967). "Hydrolysis of peptides by snake venoms of Australia and New Guinea." Aust. J. Exp. Biol. Med. Sci. 45(5): 561-7.
Ventura, M. M. (1990). "Phospholipases A2: a dendrogram from a distance matrix based on size and hydrophobicity of the residues in their homologous sequences." An-Acad-Bras-Cienc 62(2): 177-81.
Walker, F. J., W. G. Owen, et al. (1980). "Characterization of the prothrombin activator from the venom of Oxyuranus scutellatus scutellatus (taipan venom)." Biochemistry 19(5): 1020-3.
Zamudio, F., K. M. Wolf, et al. (1996). "Two novel alpha-neurotoxins isolated from the taipan snake, Oxyuranus scutellatus, exhibit reduced affinity for nicotinic acetylcholine receptors in brain and skeletal muscle." Biochemistry 35(24): 7910-6.
Ziegler, A. (1978). "Effects of taipoxin on cholinergic and adrenergic transmission in the guinea pig atrium." Neuroscience 3(4-5): 469-72.
Back to Venom Database main page
